Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and womens health, among others. It also offers business-to-business services such as product development, registration and contract manufacturing. The companys drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets products in the Middle East, Latin America, Africa, Europe and Asia. Acino is headquartered in Zurich, Switzerland.

Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Acino International AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Acino Pharma Acquires Three Products from Tabuk Pharma 11
Acino International Acquires Manufacturing Business from Takeda Pharma 12
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 15
Private Equity 17
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 17
Partnerships 18
Acino International Enters into Distribution Agreement with Merck 18
Licensing Agreements 19
Acino Pharma Enters into Licensing Agreement with AFT Pharma 19
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 20
Asset Transactions 21
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 21
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 22
Acquisition 23
Acino Pharma Acquires Litha Healthcare from Endo International 23
Acino Pharma Acquires Pharma Start 24
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 25
Acino International AG - Key Competitors 27
Acino International AG - Key Employees 28
Acino International AG - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 31
Corporate Communications 31
Jun 04, 2018: Steffen Saltofte appointed CEO Acino Group 31
Feb 15, 2017: Appointment of Mario Ricard as COO and member of the Executive Committee 32
Jan 23, 2017: Resignation of Barthold Piening, Chief Operations Officer 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables


Acino International AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Acino Pharma Acquires Three Products from Tabuk Pharma 11
Acino International Acquires Manufacturing Business from Takeda Pharma 12
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 15
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 17
Acino International Enters into Distribution Agreement with Merck 18
Acino Pharma Enters into Licensing Agreement with AFT Pharma 19
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 20
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 21
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 22
Acino Pharma Acquires Litha Healthcare from Endo International 23
Acino Pharma Acquires Pharma Start 24
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 25
Acino International AG, Key Competitors 27
Acino International AG, Key Employees 28
Acino International AG, Subsidiaries 29

List Of Figures


Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9

Acino International AG - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology

USD 250 View Report

Acino International AG Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Acino International AG Company Profile is a detailed strategic and analytical report on Acino International AG. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

EFG International AG - Strategy, SWOT and Corporate Finance Report

EFG International AG - Strategy, SWOT and Corporate Finance ReportEFG International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Acino International AG - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available